LMNL
Liminal Biosciences Inc

5,018
Loading...
Loading...
Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach. The firm has business operations in Canada and the United Kingdom. Its small molecule product candidate, fezagepras, has completed a Phase 1 multi-ascending dose clinical trial and anticipate conducting a comparative Phase 1a single ascending dose clinical trial to provide comparative data to support development plan. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Liminal Biosciences Inc?
What is the 52-week high for Liminal Biosciences Inc?
What is the 52-week low for Liminal Biosciences Inc?
What is Liminal Biosciences Inc stock price today?
What was Liminal Biosciences Inc stock price yesterday?
What is the PE ratio of Liminal Biosciences Inc?
What is the Price-to-Book ratio of Liminal Biosciences Inc?
What is Liminal Biosciences Inc's EBITDA?
What is the 50-day moving average of Liminal Biosciences Inc?

Latest LMNL News

View
No LMNL news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.